A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study)
- Manzia, Tommaso Maria
- Carmellini, Mario
- Todeschini, Paola
- Secchi, Antonio
- Sandrini, Silvio
- Minetti, Enrico
- Furian, Lucrezia
- Spagnoletti, Gionata
- Pisani, Francesco
- Piredda, Gian Benedetto
- Cappelli, Gianni
- Tisone, Giuseppe
Publication date
January 2020
DOI Publisher
Ovid Technologies (Wolters Kluwer Health)Abstract
The risk of Wound Healing Complications (WHC) and the early use of mTORi after Kidney Transplantation (KT) have not been fully addressed
Add to ORKG